Table 5.
Mean loss of FEV1 between pre‐ and postinfectious disease periods in patients with URTID, LRTID, or asymptomatic status
| Disease status | 1 mo | 3 mo | 6 mo | ||||||
|---|---|---|---|---|---|---|---|---|---|
| FEV1 (95% CI) | na | p‐value | FEV1 (95% CI) | na | p‐value | FEV1 (95% CI) | na | p‐value | |
| URTID | 90 (20–160) | 21 | 0.03 | 0 (−80 to 60) | 37 | 0.7 | 40 (−60 to 140) | 43 | 0.9 |
| LRTID | 140 (−20 to 300) | 17 | 0.03 | 130 (10–260) | 21 | 0.04 | 100 (−90 to 290) | 24 | 0.7 |
| Asymptomatic | 110 (−110 to 330) | 9 | 0.21 | 10 (−150 to 170) | 16 | 0.9 | 5 (−100 to 30) | 23 | 0.2 |
FEV1 is given in milliliters. CI, confidence interval; FEV1, forced expiratory volume; LRTID, lower respiratory tract infectious disease; URTID, upper respiratory tract infectious disease;
a
Number of lung transplant recipients who received spirometric tests.